1 | challenges | 4,306 |
2 | themes | 1,220 |
3 | lessons | 791 |
4 | hurdles | 91 |
5 | subthemes | 37 |
6 | frontiers | 34 |
7 | bottlenecks | 26 |
8 | auditorily | 9 |
9 | counter-measures | 7 |
10 | n348i | 6 |
11 | apprehensions | 5 |
12 | barriers/facilitators | 5 |
13 | importations | 4 |
14 | seeders | 4 |
15 | sub-networks | 4 |
16 | basidiospores | 3 |
17 | pheos | 3 |
18 | roadblock | 3 |
19 | staff-caregivers | 3 |
20 | vivisection | 3 |
21 | 'cholesterol | 2 |
22 | bed-t | 2 |
23 | channel-kinases | 2 |
24 | labor- | 2 |
25 | urochordates | 2 |
26 | 'lessons | 1 |
27 | 1,4-substituted-1,2,3-triazole | 1 |
28 | 5521°c/min | 1 |
29 | achievement/efficacy | 1 |
30 | cost/daly | 1 |
31 | cost/qalys | 1 |
32 | hiv/hepatitis/std | 1 |
33 | key-compounds | 1 |
34 | lipoids | 1 |
35 | nwcrc | 1 |
36 | peptide-5 | 1 |
37 | pharmaokinetic | 1 |
38 | pipefishes | 1 |
39 | pointsfive | 1 |
40 | polyuria.we | 1 |
41 | rearward | 1 |
42 | subnanotubes | 1 |
43 | trainer-are | 1 |
44 | treatment-practice | 1 |
45 | triglycerides- | 1 |
46 | £7090/qaly | 1 |
1 | 'cholesterol | 2 |
2 | 'lessons | 1 |
3 | 1,4-substituted-1,2,3-triazole | 1 |
4 | 5521°c/min | 1 |
5 | achievement/efficacy | 1 |
6 | apprehensions | 5 |
7 | auditorily | 9 |
8 | barriers/facilitators | 5 |
9 | basidiospores | 3 |
10 | bed-t | 2 |
11 | bottlenecks | 26 |
12 | challenges | 4,306 |
13 | channel-kinases | 2 |
14 | cost/daly | 1 |
15 | cost/qalys | 1 |
16 | counter-measures | 7 |
17 | frontiers | 34 |
18 | hiv/hepatitis/std | 1 |
19 | hurdles | 91 |
20 | importations | 4 |
21 | key-compounds | 1 |
22 | labor- | 2 |
23 | lessons | 791 |
24 | lipoids | 1 |
25 | n348i | 6 |
26 | nwcrc | 1 |
27 | peptide-5 | 1 |
28 | pharmaokinetic | 1 |
29 | pheos | 3 |
30 | pipefishes | 1 |
31 | pointsfive | 1 |
32 | polyuria.we | 1 |
33 | rearward | 1 |
34 | roadblock | 3 |
35 | seeders | 4 |
36 | staff-caregivers | 3 |
37 | sub-networks | 4 |
38 | subnanotubes | 1 |
39 | subthemes | 37 |
40 | themes | 1,220 |
41 | trainer-are | 1 |
42 | treatment-practice | 1 |
43 | triglycerides- | 1 |
44 | urochordates | 2 |
45 | vivisection | 3 |
46 | £7090/qaly | 1 |
1 | labor- | 2 |
2 | triglycerides- | 1 |
3 | peptide-5 | 1 |
4 | pharmaokinetic | 1 |
5 | nwcrc | 1 |
6 | rearward | 1 |
7 | hiv/hepatitis/std | 1 |
8 | treatment-practice | 1 |
9 | 1,4-substituted-1,2,3-triazole | 1 |
10 | trainer-are | 1 |
11 | pointsfive | 1 |
12 | polyuria.we | 1 |
13 | n348i | 6 |
14 | roadblock | 3 |
15 | 'cholesterol | 2 |
16 | 5521°c/min | 1 |
17 | vivisection | 3 |
18 | lipoids | 1 |
19 | key-compounds | 1 |
20 | subnanotubes | 1 |
21 | challenges | 4,306 |
22 | pipefishes | 1 |
23 | hurdles | 91 |
24 | themes | 1,220 |
25 | subthemes | 37 |
26 | basidiospores | 3 |
27 | counter-measures | 7 |
28 | channel-kinases | 2 |
29 | urochordates | 2 |
30 | bottlenecks | 26 |
31 | sub-networks | 4 |
32 | apprehensions | 5 |
33 | importations | 4 |
34 | lessons | 791 |
35 | 'lessons | 1 |
36 | pheos | 3 |
37 | seeders | 4 |
38 | frontiers | 34 |
39 | staff-caregivers | 3 |
40 | barriers/facilitators | 5 |
41 | cost/qalys | 1 |
42 | bed-t | 2 |
43 | achievement/efficacy | 1 |
44 | cost/daly | 1 |
45 | £7090/qaly | 1 |
46 | auditorily | 9 |